Cleveland Diagnostics Revenue and Competitors
Estimated Revenue & Valuation
- Cleveland Diagnostics's estimated annual revenue is currently $10.8M per year.
- Cleveland Diagnostics's estimated revenue per employee is $139,103
- Cleveland Diagnostics's total funding is $112M.
Employee Data
- Cleveland Diagnostics has 78 Employees.
- Cleveland Diagnostics grew their employee count by 20% last year.
Cleveland Diagnostics's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Operating Officer | Reveal Email/Phone |
2 | Director IT | Reveal Email/Phone |
3 | Chief Commercial Officer | Reveal Email/Phone |
4 | Chief Medical Officer | Reveal Email/Phone |
5 | Associate Director, Marketing | Reveal Email/Phone |
6 | Senior Finance Director | Reveal Email/Phone |
7 | Director Research and Development (Assay, Reagents and Product Development) | Reveal Email/Phone |
8 | Principal Automation Engineer | Reveal Email/Phone |
9 | Researcher | Reveal Email/Phone |
Cleveland Diagnostics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.8M | 3 | -25% | N/A | N/A |
#2 | $1.7M | 11 | 0% | N/A | N/A |
#3 | $0.8M | 4 | 0% | N/A | N/A |
#4 | $5.1M | 33 | 14% | N/A | N/A |
#5 | $64.6M | 363 | 6% | N/A | N/A |
#6 | $1.7M | 10 | 11% | N/A | N/A |
#7 | $0.8M | 13 | 225% | N/A | N/A |
#8 | $7.4M | 37 | -5% | N/A | N/A |
#9 | $0.6M | 3 | 0% | N/A | N/A |
#10 | $0.9M | 10 | -9% | N/A | N/A |
What Is Cleveland Diagnostics?
Cleveland Diagnostics is developing a breakthrough technology to discover a new class of diagnostics tests with high sensitivity and specificity for many cancers – early on, when cancer is still curable.
keywords:N/A$112M
Total Funding
78
Number of Employees
$10.8M
Revenue (est)
20%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Cleveland Diagnostics News
2022-04-20 - Prostate Specific Antigen (PSA) Blood Based Biomarker ...
ProteoMediX; Cleveland Diagnostics; Roche; GENFIT; Randox; Minomic; Nutech Cancer Biomarkers; Creative Diagnostics; OGT (Sysmex Group). Prostate Specific...
2022-04-19 - Worldwide Blood Based Biomarker Industry to 2030 - Featuring Sysmex,
Minomic and C2N Diagnostics Among Others
... to 2030 - Featuring Sysmex, Minomic and C2N Diagnostics Among Others ... Proteomedix, Cleveland Diagnostics, F. Hoffmann-La Roche Ltd,...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $15.3M | 78 | 59% | N/A |
#2 | $13.7M | 78 | -6% | N/A |
#3 | $7.5M | 78 | 7% | N/A |
#4 | $14.9M | 78 | 34% | N/A |
#5 | $34.7M | 79 | -4% | N/A |